Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Future treatment modalities for meningiomas: targeting of neurofibromatosis type 2 and Ras-regulated pathways.

Evans JJ, Lee JH, Park YS, Jeun SS, Harwalkar JA, Safayhi H, Golubic M.

Neurosurg Clin N Am. 2000 Oct;11(4):717-33. No abstract available.

PMID:
11082181
[PubMed - indexed for MEDLINE]
2.

Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer.

Ikeda K, Saeki Y, Gonzalez-Agosti C, Ramesh V, Chiocca EA.

J Neurosurg. 1999 Jul;91(1):85-92.

PMID:
10389885
[PubMed - indexed for MEDLINE]
3.

Molecular genetics of meningiomas: from basic research to potential clinical applications.

Simon M, Boström JP, Hartmann C.

Neurosurgery. 2007 May;60(5):787-98; discussion 787-98. Review.

PMID:
17460514
[PubMed - indexed for MEDLINE]
4.

Meningiomas and neurofibromatosis for the oncologist.

Schrell UM, Fahlbusch R, Adams EF.

Curr Opin Oncol. 1994 May;6(3):247-53. Review. Erratum in: Curr Opin Oncol 1994 Jul;6(4):452.

PMID:
8080853
[PubMed - indexed for MEDLINE]
5.

Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas.

Joachim T, Ram Z, Rappaport ZH, Simon M, Schramm J, Wiestler OD, von Deimling A.

Int J Cancer. 2001 Oct 15;94(2):218-21.

PMID:
11668501
[PubMed - indexed for MEDLINE]
6.

Current standing and frontiers of gene therapy for meningiomas.

De La Garza-Ramos R, Flores-Rodríguez JV, Martínez-Gutiérrez JC, Ruiz-Valls A, Caro-Osorio E.

Neurosurg Focus. 2013 Dec;35(6):E4. doi: 10.3171/2013.8.FOCUS13305. Review.

PMID:
24289129
[PubMed - indexed for MEDLINE]
7.

Novel therapies for meningiomas.

Wen PY, Drappatz J.

Expert Rev Neurother. 2006 Oct;6(10):1447-64. Review.

PMID:
17078786
[PubMed - indexed for MEDLINE]
8.

Molecular genetics of meningiomas.

Ng HK.

Asian J Surg. 2005 Jan;28(1):11-2. No abstract available.

PMID:
15691790
[PubMed - indexed for MEDLINE]
9.

Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms.

Pham MH, Zada G, Mosich GM, Chen TC, Giannotta SL, Wang K, Mack WJ.

Neurosurg Focus. 2011 May;30(5):E7. doi: 10.3171/2011.2.FOCUS1117. Review.

PMID:
21529178
[PubMed - indexed for MEDLINE]
10.

Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.

Lomas J, Bello MJ, Alonso ME, Gonzalez-Gomez P, Arjona D, Kusak ME, de Campos JM, Sarasa JL, Rey JA.

Hum Pathol. 2002 Mar;33(3):375-8.

PMID:
11979381
[PubMed - indexed for MEDLINE]
11.

New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Johnson MD, Sade B, Milano MT, Lee JH, Toms SA.

J Neurooncol. 2008 Jan;86(1):109-22. Epub 2007 Jul 12. Review.

PMID:
17624496
[PubMed - indexed for MEDLINE]
12.

Current treatment of meningiomas.

McDermott MW.

Curr Opin Neurol. 1996 Dec;9(6):409-13. Review.

PMID:
9007396
[PubMed - indexed for MEDLINE]
13.

Pediatric meningioma: current approaches and future direction.

Kotecha RS, Junckerstorff RC, Lee S, Cole CH, Gottardo NG.

J Neurooncol. 2011 Aug;104(1):1-10. doi: 10.1007/s11060-010-0503-3. Epub 2011 Jan 4. Review.

PMID:
21203895
[PubMed - indexed for MEDLINE]
14.

New insights into meningioma: from genetics to trials.

Vranic A, Peyre M, Kalamarides M.

Curr Opin Oncol. 2012 Nov;24(6):660-5. doi: 10.1097/CCO.0b013e3283571a06. Review.

PMID:
22820412
[PubMed - indexed for MEDLINE]
15.

[Nonsurgical methods in the treatment of meningiomas].

Kozlov AV.

Zh Vopr Neirokhir Im N N Burdenko. 2001 Apr-Jun;(2):29-32; discussion 32. Review. Russian. No abstract available.

PMID:
11558171
[PubMed - indexed for MEDLINE]
16.

Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization.

Begnami MD, Rushing EJ, Santi M, Quezado M.

Int J Surg Pathol. 2007 Apr;15(2):110-5.

PMID:
17478763
[PubMed - indexed for MEDLINE]
17.

NF2 mutations in secretory and other rare variants of meningiomas.

Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A.

Brain Pathol. 2006 Jan;16(1):15-9.

PMID:
16612978
[PubMed - indexed for MEDLINE]
18.

[Meningiomas: new prognostic factors].

Sanz Esponera J.

An R Acad Nac Med (Madr). 2007;124(2):319-32; discussion 330-2. Spanish.

PMID:
18069599
[PubMed - indexed for MEDLINE]
19.

Molecular genetics of meningiomas.

Ragel BT, Jensen RL.

Neurosurg Focus. 2005 Nov 15;19(5):E9. Review.

PMID:
16398473
[PubMed - indexed for MEDLINE]
20.

Genomic analysis of non-neurofibromatosis type 2 meningiomas.

Parry PV, Engh JA.

Neurosurgery. 2013 Jun;72(6):N18-9. doi: 10.1227/01.neu.0000430737.55867.9f. No abstract available.

PMID:
23685513
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk